In this webinar, Dr. Emma Gibbin-Lameira will show how Nanolive’s label-free, non-invasive imaging can be used to quantify dose-dependent responses of HeLa cells to Chloroquine.
Specifically, Dr. Gibbin-Lameira will show that:
- Dose-dependent experiments can be performed in 96-well plate format over long periods of time (> 2 days), reducing the need for time and labor-intensive multiple fixed-point measurements and eliminating cytotoxic/cytostatic effects arising from the use of labels, dyes, or phototoxic damage
- Metrics output from Nanolive’s proprietary software, EVE Analytics, can be used to generate statistically robust time-dependent EC50 values based on total dry mass; a metric unique to label-free imaging
- Sub-cellular spatial resolution combined with high content image analysis can be used to investigate a drugs’ mechanism of action
Please register below to watch the webinar on-demand.
Read our latest news
Seminar – Label-Free Live Cell Analysis: Applications in Cancer Cell Death and Immune Engineering
Get a look into Nanolive’s workflow in this on-demand Online Demo, as our Field Application Specialist, Matthias Schade, guides us through the insights gained from a high content phenotypic screen.
Measuring CAR T potency with label-free imaging
Discover case study data from scientists at UPenn demonstrating a label-free CAR T cytotoxicity assay, with high resolution CAR T cell images.
Online demo: Rethink high content screening workflows for smarter decisions
Get a look into Nanolive’s workflow in this on-demand Online Demo, as our Field Application Specialist, Matthias Schade, guides us through the insights gained from a high content phenotypic screen.